Aegion Corp (AEGN)

29.99  -0.01 (-0.03%)

After market: 29.95 -0.04 (-0.13%)

Fundamental Rating

1

Overall AEGN gets a fundamental rating of 1 out of 10. We evaluated AEGN against 0 industry peers in the Unkown industry. AEGN has a bad profitability rating. Also its financial health evaluation is rather negative. AEGN has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

AEGN had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -3.31%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -0.54%
PM (TTM) -3.24%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

AEGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.91 indicates that AEGN is not a great score, but indicates only limited risk for bankruptcy at the moment.
AEGN has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF N/A
Altman-Z 2.91
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

AEGN has a Current Ratio of 2.14. This indicates that AEGN is financially healthy and has no problem in meeting its short term obligations.
AEGN has a Quick Ratio of 1.92. This is a normal value and indicates that AEGN is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 2.14
Quick Ratio 1.92

1

3. Growth

3.1 Past

AEGN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.31%.
The Earnings Per Share has been decreasing by -3.88% on average over the past years.
Looking at the last year, AEGN shows a very negative growth in Revenue. The Revenue has decreased by -25.88% in the last year.
AEGN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.54% yearly.
EPS 1Y (TTM)-21.31%
EPS 3YN/A
EPS 5Y-3.88%
EPS growth Q2Q33.33%
Revenue 1Y (TTM)-25.88%
Revenue growth 3YN/A
Revenue growth 5Y-9.54%
Revenue growth Q2Q-36.95%

3.2 Future

Based on estimates for the next years, AEGN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.67% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y7.62%
EPS Next 2Y8.67%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 31.24, AEGN can be considered very expensive at the moment.
Compared to an average S&P500 Price/Earnings ratio of 28.28, AEGN is valued at the same level.
Based on the Price/Forward Earnings ratio of 24.19, the valuation of AEGN can be described as rather expensive.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.88, AEGN is valued at the same level.
Industry RankSector Rank
PE 31.24
Fwd PE 24.19

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 47.77

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.1
PEG (5Y)N/A
EPS Next 2Y8.67%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AEGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

Aegion Corp

NASDAQ:AEGN (5/14/2021, 7:21:15 PM)

After market: 29.95 -0.04 (-0.13%)

29.99

-0.01 (-0.03%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap922.49M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 31.24
Fwd PE 24.19
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)4.1
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.31%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -0.54%
PM (TTM) -3.24%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.14
Quick Ratio 1.92
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-21.31%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y7.62%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-25.88%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y